Abstract The docosahexaenoic acid (DHA) biosynthesis gene cluster (pDHA3) from the DHA-producing Moritella marina strain MP-1 includes the genes pfaA, pfaB, pfaC, and pfaD, which are similar to the genes of polyketide biosynthesis. When this cluster was co-expressed in Escherichia coli with M. marina MP-1 pfaE, which encodes phosphopantetheinyl transferase, DHA was biosynthesized. The maximum production of DHA (5% of total fatty acids) was observed at 15 C. This is the first report of the recombinant production of DHA in a polyketide biosynthesis mode.
Introduction
Polyunsaturated fatty acids (PUFAs), such as eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA), are formed in organisms by a combination of the elongation and desaturation of either C 16 or C 18 fatty acids or by enzyme systems consisting of polyketide synthases (PKSs), which form PUFAs from C 2 compounds (possibly acetyl-CoA). Therefore, the recombinant production of PUFAs that are of pharmaceutical and nutritional importance (Bezard et al. 1994; Gill and Valivety 1997) has been attempted using these two systems: reconstruction of the stepwise reaction processes of elongation and desaturation of predominantly C 18 fatty acids that occur in transgenic plants Robert 2006) or the introduction of a single set of PKS genes into host bacteria (Metz et al. 2001; Orikasa et al. 2004) .
Recently, significant levels of arachidonic acid, EPA, and DHA were produced in Brassica juncea (Wu et al. 2004) and Arabidopsis thaliana (Robert 2006) , and EPA and DHA in Glycine max (Kinney et al. 2004 ) when the plants were metabolically engineered in a stepwise manner. Using the PKS enzyme system, only the transgenic production of EPA was successfully achieved in Escherichia coli (Orikasa et al. 2004; Nishida et al. 2006 ) and cyanobacteria (Takeyama et al. 1997; Yu et al. 2000) . Orikasa et al. (2004) developed various recombinant systems involving clustered polyketide-like synthesis genes (the EPA gene cluster) that had been obtained from EPA-producing Shewanella pneumatophori SCRC-2738 [formerly Shewanella sp. SCRC-2738 (Hirota et al. 2005; hereafter called SCRC-2738] . Significantly high levels of EPA, comprising more than 20% of the total fatty acids, were thus formed in E. coli (Orikasa et al. 2004) . Tanaka et al. (1999) cloned clustered genes (the DHA gene cluster) as a cosmid genomic clone of p3D5, with a 40-kbp insert from Moritella marina strain MP-1 (hereafter called MP-1). This DHA gene cluster consisted of four genes, pfaA, pfaB, pfaC, and pfaD, which are highly homologous to those included in the EPA gene cluster of SCRC-2738. They are also highly homologous to the corresponding genes of other EPA-producing bacteria (Allen and Bartlett 2002; Gentile et al. 2003) and to those of bacteria expected (but not yet confirmed) to produce DHA (Methe et al. 2005) . However, the DHA gene cluster from MP-1 lacks a gene corresponding to pfaE. The domain structure of each pfa gene of the DHA gene cluster of MP-1 is as follows: pfaA encodes a multifunction protein including domains for 3-ketoacyl synthase (KS), malonyl-CoA:acyl carrier protein (ACP) acyltransferase (AT), five ACP repeats, and 3-ketoacyl-ACP reductase (KR). pfaC encodes a protein with domains of two KS repeats, chainlength factor, and two 3-hydroxydecanoyl-ACP dehydratases (HD). A very recent BLAST search indicated that pfaC of the DHA gene cluster and also of the EPA gene cluster of SCRC-2738 includes one additional HD region (see Fig. 1 ). Genes pfaB and pfaD encode proteins with KR and AT domains and an enoyl reductase (ER) domain, respectively (Tanaka et al. 1999 ).
Although we constructed a high-copy-number plasmid vector (pDHA2) that carried pfaA-D by modifying p3D5 of MP-1 and p3D5 and pDHA2 were transformed into Escherichia coli already carrying a pfaE gene to produce DHA, no DHA was produced. We then identified a single-nucleotide replacement in the pfaA gene of the DHA gene cluster in p3D5 and pDHA2, which inactivated the gene. However, a plasmid vector (pDHA3) with the native nucleotide sequence was subsequently constructed. Thus, the recombinant production of DHA was achieved by combining pDHA3 and pfaE from MP-1.
Materials and methods
Bacterial strains and culture conditions Table 1 summarizes the bacterial strains and vectors used in this study. Escherichia coli DH5a recombinant cells were cultured with shaking in Luria-Bertani (LB) medium supplemented with the indicated antibiotics at 37 C for 16 h. An aliquot of the 37 C-grown precultured E. coli DH5a cells carrying one or two vectors was transferred to 3 ml of fresh LB medium in a test tube and then cultured with shaking at 180 rpm at 15 C for 96 h to allow DHA production. Cells carrying pSTV29 and those carrying pET21a or the pCR2.1-TOPO vector (pTOPO, Invitrogen) were cultured in LB medium containing chloramphenicol at 30 lg/ml and ampicillin at 50 lg/ ml, respectively. When the temperature-dependent production of DHA was investigated, the recombinant E. coli DH5a cells were cultured in 10 ml LB medium in a 50 ml flask at 180 rpm at 10, 15, 20, or 25 C. The cells were harvested at mid-to late-growth phase and subjected to fattyacid analysis. Moritella marina strain MP-1 (ATCC 15381) was cultured in LB medium containing 3% (w/v) NaCl at 15 C for 96 h. A comparison of our nucleotide sequence (AB025342) for the whole DHA gene cluster from MP-1 with the corresponding sequence reported by Facciotti et al. (1998) indicated that there was a disagreement in one nucleotide of the pfaA gene region in the p3D5 and pDHA2 sequences. Resequencing the 250-bp region of the genomic DNA of MP-1, including the contentious sequence, revealed the base replacement of ''C'' with ''T'' (see below) at nucleotide 1,190 of the pfaA gene in p3D5 and in its derivative, pDHA2. The vector carrying the corrected sequence of the pfaA gene was prepared as follows. The region including the replacement nucleotide, between restriction sites PmeI and MluI within the pfaA gene, was amplified by PCR using the forward and reverse primers 5 -GGTGAAGGTATTGG-CATGAT-3 and 5 -ATCTTCACGTGGCATC-CAAG-3 , and the genomic DNA of MP-1 as the template. The resulting DNA fragment (pfaApm) of 484 bp was cloned into the pTOPO vector (pTOPO::pfaApm). pTOPO::pfaApm was treated with PmeI and then with MluI. The digests were purified by electrophoresis on agarose gels. The resulting DNA fragment of 450 bp was ligated to PmeI-and MluI-digested pDHA2, producing pDHA3. pDHA3 is a pSTV29 vector carrying the complete sequence of pfaA-D.
The phosphopantetheinyl transferase (PPTase) gene (pfaE) of MP-1, which had been integrated into pET21a (pET21a::pfaE), was prepared as described previously . The chromosomal DNA of MP-1 was isolated according to the procedure described previously (Tanaka et al. 1999) . Determination of the nucleotide sequences and their analysis were carried out as described previously ).
GLC and GC-MS analyses of fatty acids
Fatty acids were analyzed as their methyl esters (FAMEs), as described previously . To identify DHA, total FAMEs were converted to their pyrrolidide adducts and then subjected to gas chromatography/mass spectrometry (GC/MS), as described previously .
Results and discussion
Recombinant production of DHA using pDHA3 GC analysis of the total FAMEs of the recombinant E. coli DH5a cells carrying pDHA3 and pET21a::pfaE, grown at 15°C, showed the occurrence of a peak with a retention time of 31.2 min, which was not detected in the control E. coli DH5a cells carrying no vector. The retention time of this unknown component was the same as that of authentic DHA (data not shown). GC/MS analysis of the pyrrolidide derivative of the component detected an [M] + ion at m/z 382. A series of ions at m/z 113, 126, 138, 152, 166, 178, 192, 206, 218, 232, 246, 258, 272, 286, 298, 312, 326, 338, 352, and 366 showed the positions of double bonds at D4, 7, 10, 13, 16, and 19, suggesting that this fatty acid was DHA (Watanabe 2000) . These results indicate that this component was DHA and that it comprised up to 3% (w/w) of the total fatty acids when the cells were cultivated at 15 C in test tubes.
As shown in Fig. 1, pDHA3 included the complete sequences of ORFs 5, 6, and 7 and the partial sequences of ORFs 4 and 12, in addition to pfaA-D. Although the functions of ORFs 5-7 have not been identified, as was the case in the biosynthesis of EPA (Orikasa et al. 2004) , only the genes pfaA-E would be required for the biosynthesis of DHA. (Fig. 2) . More DHA was produced in cells cultured in flasks (5% of total fatty acids) than in those cultured in test tubes (3% of total fatty acids) at the same temperature (15 C). Because it is expected that the liquid medium in a flask is better aerated than that in a test tube, the concentration of dissolved O 2 could have affected the recombinant production of DHA (Fig. 3) .
According to Orikasa et al. (2004) , higher levels (approx. 16%) of EPA were produced when E. coli cells were transformed with highcopy-number plasmid (pNEB) carrying the EPA gene cluster compared with those produced by cells transformed with a cosmid vector carrying pfaA-E. Much higher levels of EPA (approx. 22%) were produced by the cotransformation of a plasmid vector carrying a pfaE-deficient EPA gene cluster and another high-copy-number vector carrying pfaE (Orikasa et al. 2004) . That result suggested that the relative ratio of PPTase protein to the other EPA biosynthesis enzymes is a significant factor in the production of EPA (Orikasa et al. 2004) . The level of DHA in the present study was approximately 5% of the total fatty acids in the recombinant E. coli DH5a cells co-expressing pDHA3 and pfaE from MP-1 in flasks at 15 C (Table 1) . However, this value could be increased by the appropriate selection and combination of the two plasmid vectors and/ or host organisms, and optimized culture conditions.
Although the domain structures of the clustered genes responsible for the biosynthesis of EPA and DHA are similar, there are some differences between the pfaA-D genes of MP-1 and those of SCRC-2738. The former has five ACP repeats in pfaA (Tanaka et al. 1999) , whereas the latter has six repeats (Orikasa et al. 2004 ). However, this would not determine the final production of EPA or DHA, because the pfaA gene of EPA-producing Photobacterium profundam SS9 has five ACP repeats (Allen and Bartlett 2002) . Interestingly, pfaB of MP-1 has a KS domain which is not present in the corresponding pfaB gene of SCRC-2738. The presence of one additional KS domain in the DHA gene cluster might be associated with the elongation of the C 20 to the C 22 fatty acid and ultimately with the biosynthesis of DHA.
The use of PKS genes to produce EPA or DHA in heterologous host organisms has various benefits. (1) The PKS system has a metabolic advantage. It requires less reducing equivalents, such as NADPH, to form EPA or DHA, because the double bonds formed during the growth of the acyl intermediates are left in the chains (Ratledge 2004) . (2) The procedure used to produce transgenic organisms is simple. The recombinant production of EPA, at levels higher than 20% of the total fatty acids, can be achieved by introducing only one or two vectors carrying pfa genes into 
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Temperature(˚C) Fig. 3 Effects of growth temperature on the production of DHA by E. coli DH5a carrying pDHA3 and pET21a::pfaE. Cells were cultured in flasks at various temperatures, up to mid to late exponential phase. The data are means ± S.E. for three independent experiments host cells (see Orikasa et al. 2004) . For the production of DHA, the combination of two plasmid vectors carrying either pfaA-D or pfaE is required at present. Inclusion of pfaA-E in one high-copy-number plasmid vector should result in much greater production of this fatty acid in prokaryotic host organisms. (3) The EPA and DHA gene clusters are exclusively involved in producing EPA and DHA, respectively. The compositional simplicity of unsaturated fatty acids is a great advantage for their commercial use.
